Recently, phosphorylated-Stat3 expression in the tumor stroma, an indication of IL-6-JAK pathway activation, was thought to be a critical contributor to cancer progression and response to therapy by modulating PI3K pathway [74,75]. The gene discussed is IL6; the disease is cancer.